Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) -13.55-8.98-24.46-22.972.44

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -13.55 based on Mar2026 Standalone results.
Year Core EBITDA Margin
Mar2026-13.55
Mar2025-8.98
Mar2024-24.46
Mar2023-22.97
Mar20222.44

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2026 -13.55
Negative
Mar2025 -8.98
Negative
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹174.1 Cr -1.9% -2% -26.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,150.0 Cr 0.8% -2.1% 4.8% Stock Analytics
DIVIS LABORATORIES ₹266,265.0 Cr 4.9% 7.9% 54.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr 1.6% -2.7% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹114,351.0 Cr 2.6% 14.2% 3.9% Stock Analytics
CIPLA ₹112,474.0 Cr 2.4% 3.4% -12% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-1.9%

-2%

-26.4%

SENSEX

4.5%

6.1%

-9.3%


You may also like the below Video Courses